Anti-FHR5/ CFHR5/ CFHL5D functional antibody

Anti-FHR5/ CFHR5/ CFHL5D functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to CFHR5/CFHR5 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE0079-Ab-1/ GM-Tg-hg-SE0079-Ab-2Anti-Human CFHR5 monoclonal antibodyHuman
GM-Tg-rg-SE0079-Ab-1/ GM-Tg-rg-SE0079-Ab-2Anti-Rat CFHR5 monoclonal antibodyRat
GM-Tg-mg-SE0079-Ab-1/ GM-Tg-mg-SE0079-Ab-2Anti-Mouse CFHR5 monoclonal antibodyMouse
GM-Tg-cynog-SE0079-Ab-1/ GM-Tg-cynog-SE0079-Ab-2Anti-Cynomolgus/ Rhesus macaque CFHR5 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE0079-Ab-1/ GM-Tg-felg-SE0079-Ab-2Anti-Feline CFHR5 monoclonal antibodyFeline
GM-Tg-cang-SE0079-Ab-1/ GM-Tg-cang-SE0079-Ab-2Anti-Canine CFHR5 monoclonal antibodyCanine
GM-Tg-bovg-SE0079-Ab-1/ GM-Tg-bovg-SE0079-Ab-2Anti-Bovine CFHR5 monoclonal antibodyBovine
GM-Tg-equg-SE0079-Ab-1/ GM-Tg-equg-SE0079-Ab-2Anti-Equine CFHR5 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE0079-Ab-1/ GM-Tg-hg-SE0079-Ab-2; GM-Tg-rg-SE0079-Ab-1/ GM-Tg-rg-SE0079-Ab-2;
GM-Tg-mg-SE0079-Ab-1/ GM-Tg-mg-SE0079-Ab-2; GM-Tg-cynog-SE0079-Ab-1/ GM-Tg-cynog-SE0079-Ab-2;
GM-Tg-felg-SE0079-Ab-1/ GM-Tg-felg-SE0079-Ab-2; GM-Tg-cang-SE0079-Ab-1/ GM-Tg-cang-SE0079-Ab-2;
GM-Tg-bovg-SE0079-Ab-1/ GM-Tg-bovg-SE0079-Ab-2; GM-Tg-equg-SE0079-Ab-1/ GM-Tg-equg-SE0079-Ab-2
Products NameAnti-CFHR5 monoclonal antibody
Formatmab
Target NameCFHR5
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-CFHR5 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE0079-Ag-1Recombinant multi-species FHR5/ CFHR5/ CFHL5D protein


    Target information

    Target IDGM-SE0079
    Target NameCFHR5
    Gene ID81494,106994227,490262,101091337
    Gene Symbol and SynonymsCFHL5,CFHR2,CFHR5,CFHR5D,FHR-5,FHR5
    Uniprot AccessionQ9BXR6
    Uniprot Entry NameFHR5_HUMAN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseN/A
    Gene EnsemblENSG00000134389
    Target ClassificationN/A

    The target: CFHR5, gene name: CFHR5, also named as CFHL5D, FHR-5, FHR5, CFHR5. This gene is a member of a small complement factor H (CFH) gene cluster on chromosome 1. Each member of this gene family contains multiple short consensus repeats (SCRs) typical of regulators of complement activation. The protein encoded by this gene has nine SCRs with the first two repeats having heparin binding properties, a region within repeats 5-7 having heparin binding and C reactive protein binding properties, and the C-terminal repeats being similar to a complement component 3 b (C3b) binding domain. This protein co-localizes with C3, binds C3b in a dose-dependent manner, and is recruited to tissues damaged by C-reactive protein. Allelic variations in this gene have been associated, but not causally linked, with two different forms of kidney disease: membranoproliferative glomerulonephritis type II (MPGNII) and hemolytic uraemic syndrome (HUS). [provided by RefSeq, Jan 2010].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.